The $270 central target reflects an average of recent, individually verifiable analyst price targets rather than any single firm's view, and it should not be treated as an official published consensus. Coverage remains extensive, with roughly 60-plus analysts tracked across major data providers, but the dispersion is striking. At the low end, Seaport Global's Jay Goldberg holds a Sell rating with a $130 target. Closer to the middle, UBS cut its target to $240, J.P. Morgan to $215, Citi to $225, Barclays to $210, and Stifel to $205. At the high end, Bank of America stands at $280, Morgan Stanley and Goldman Sachs near $300, and Bernstein at $400.
This unusually wide range—spanning more than $385 between the lowest and highest published figures—is driven by one question: whether NVIDIA's growth engine can keep firing without Jensen Huang at the helm and under intensifying government scrutiny. Most ratings remain Buy or equivalent, but several firms downgraded or slashed targets in November 2026 as the governance crisis unfolded.
NVIDIA shares closed at $155.46 on November 17, 2026, before rallying about 3% in after-hours trading following earnings. Reaching $270 would require an advance of roughly 74%, a very large move by any standard. The stock had already fallen about 25% during November and roughly 36% from its October 5 intraday record near $243.37, marking six straight weekly declines—its longest losing streak since 2012.
The fundamentals complicate the picture. NVIDIA reported fiscal third-quarter adjusted EPS (earnings per share) of $2.68, above the $2.48 consensus, on revenue of $115.8 billion, up 103% year over year and ahead of the roughly $109 billion expected. Fourth-quarter revenue guidance of about $130 billion also exceeded the approximately $125 billion consensus. Yet the stock remains far below its highs because the market is now pricing a governance and regulatory overhang, not just earnings power.
The core support is demand. Data-center revenue climbed roughly 110% year over year on the ramp of the Vera Rubin platform and continued Blackwell Ultra momentum. Guidance suggests AI infrastructure spending remains robust, and NVIDIA retains roughly $227 billion in unused share-repurchase authorization. If a credible permanent CEO is named, export and litigation concerns ease, and quarterly results keep beating expectations, the valuation has room to re-rate toward the average analyst price target.
The obstacles are substantial. The SEC, FBI, and the Justice and Commerce Departments are reportedly investigating the company, a shareholder class action has been filed, and the board has ruled out reinstating Huang. Export-control scrutiny targeting sales routed through markets such as Singapore and Malaysia could constrain future revenue, and Q4 guidance assumes no China data-center sales. Several analysts also flag margin compression, with gross margin guided to 71–72% from 74.8%, and the risk that financing-dependent "neocloud" customers weaken. Any of these could keep the stock far below the central target.
The October record near $243 serves as a major resistance zone, while the recent lows near $155 are the nearest support. A meaningful recovery would first need to reclaim the psychologically important $200 level, which several recently trimmed targets (Stifel, Barclays, Citi) cluster just above. The $270 target sits above the prior 52-week high, meaning the stock would need not just a rebound but a decisive breakout to new highs—a demanding technical hurdle given the current trend structure.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms may differ. Investors should watch the CEO succession process, the outcome of ongoing federal investigations, any tightening of export restrictions, Q4 results against the $130 billion guide, and the trajectory of gross margins. Further analyst target revisions—upward on a stabilizing leadership story, or downward on regulatory escalation—will be central to whether the $270 figure holds.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a stock as volatile as NVIDIA, where sentiment can shift rapidly, this kind of automated monitoring can help traders discover opportunities, keep track of positions, and identify turning trends more efficiently than manual review. Explore the signals to complement your own research process.
Whether NVIDIA can reach $270 hinges less on its earnings power—which remains formidable—and more on resolving the leadership and regulatory crisis that has crushed its valuation. The central target represents an average of analyst price targets spanning $130 to $515, and the 74% move required is very large. Blowout results and strong AI demand provide a credible foundation, but export restrictions, litigation, and margin pressure are genuine obstacles. The next catalysts—a permanent CEO, investigative outcomes, and Q4 execution—will determine whether the stock can rebuild toward that level. No outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, NVDA has been closely correlated with LRCX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVDA jumps, then LRCX could also see price increases.
| Ticker / NAME | Correlation To NVDA | 1D Price Change % | ||
|---|---|---|---|---|
| NVDA | 100% | -14.01% | ||
| LRCX - NVDA | 70% Closely correlated | -10.02% | ||
| KLAC - NVDA | 69% Closely correlated | -10.33% | ||
| AMAT - NVDA | 66% Closely correlated | -10.71% | ||
| AMKR - NVDA | 63% Loosely correlated | -11.40% | ||
| CAMT - NVDA | 63% Loosely correlated | -8.77% | ||
More | ||||